improv momentum
setup remain posit track think move
forward continu make solid progress goals/target note
out-performance come earlier expect benefit
higher level rebat gener launch better expect omnicar
perform faster expect synergi alongsid ep benefit ytd
invest gain pyd despit notion pull-forward relat
follow-up convers lead us believ overarch
framework analyst day larg remain
backdrop adjust start point ep relat
manag target least ep continu see hcb aetna
busi core driver growth key sinc hcb area great
investor skeptic merger close due execut departur etc
color oper segment expect hcb busi grow
ebit roughli in-lin compani guidanc hsd ebit growth
pbm side promis see new busi win help off-set
variou loss compani experienc promisingli rebat gener
benefit pbm howev unclear fulli off-set known pbm
custom loss expect see pbm ebit within
guidanc rang msd declin retail segment remain somewhat cautiou
rx reimburs pressur persist omnicar busi
perform better expect remain unpredict due end market
volatil within omnicar client base project retail ebit growth
low end compani lsd ebit growth rang slightli
conserv retail ebit updat ep howev
rais pt higher price-to-earnings due greater clariti
hcb aetna strength given continu medicar advantag growth
particular well stabl trend figur color view
quarterli annual ep usd
consensu number bloomberg receiv gmt
barclay capit inc and/or one affili seek busi
compani cover research report result investor awar
firm may conflict interest could affect object report investor
consid report singl factor make invest decis
rais usd
return equiti ttm
link barclay live interact chart
overweight combin aetna set
compani path off-set slower-growth
retail pbm busi fast-grow aetna
busi expect acceler growth
establish key healthcar partner
upsid case see better expect synergi
cross sell product improv medic loss
ratio combin retail pbm
posit trend compani retail/pbm
busi would lead multipl expans
downsid case see slower expect
synergi aetna transact misstep
handl insur portion busi
coupl continu loss retail/pbm
busi lead multipl contraciton
margin return data
balanc sheet cash flow mn
equival
short long-term debt
chang work capit
flow oper
valuat leverag metric
 guidanc outlookenterpris segment outlook retail milretail/ltc ebit servic servic lsdup lsd benefit outlook year end medic mlnadjust /- bp higher /- bp mid-pt hcb commerci medic /- /- bpscorpor segment mlnother itemsinterest mlntax net incom operationsadjust mlnincrement invest mlnenterpris mlnpss mlnrss mlnhcb mlncash avail debt barclay
 guidanc revenueup low singl digitretail segment outlook revenu growthup low mid singl digitsretail/ltc ebit growthup low singl digitspharmaci servic outlook revenuedown low mid singl digitspharmaci servic ebit growthdown mid-singl digit benefit outlook revenu growthup mid-singl digitshcb ebitup high singl digitstax least ep outlookmid-singl digit ep outlooklow doubl digit growth barclay
expect analyst day
hcbdivestitur aetna pdpcompetit environ insur fee reinstatementdivestitur aetna pdp strand costsoutpac industri growth govern servic insur fee reinstatmentoutpac industri growth govern servicessynergi enterpris modernizationtransformationretailfront store continu shift digitalfront store marginfront store format personalizationgenericsomnicareomnicareoutpac industri growth rxreimburs pressurerx growthsynergi enterpris modernizationpbmanthemanthemnet new busi migrationsnet new busi migrationsspecialtypr pressurepurchas economicsreb guaranteesspecialtysynergi enterpris revenu low-to-mid singl digit adj op incom low singl digit total revenuesadjust oper revenu low-to-mid singl digit adj op incom mid-singl digit revenu mid-singl digit adj op incom high singl digit total revenuesadjust oper incometot revenuesadjust oper incom barclay
steve valiquett herebi certifi view express research report accur reflect person view
subject secur issuer refer research report part compens directli indirectli relat
specif recommend view express research report
barclay research produc invest bank barclay bank plc affili collect individu barclay
author contribut research report research analyst unless otherwis indic public date top report
reflect local time report produc may differ releas date provid gmt
avail disclosur
compani subject research report current import disclosur regard compani pleas refer
http //publicresearch barclay com altern send written request barclay research complianc seventh avenu floor
new york ny call
analyst respons prepar research report receiv compens base upon variou factor includ firm total
revenu portion gener invest bank activ profit revenu market busi
potenti interest firm invest client research respect asset class cover analyst
analyst regularli conduct site visit view materi oper cover compani barclay polici prohibit accept
payment reimburs cover compani travel expens visit
barclay research depart produc variou type research includ limit fundament analysi equity-link analysi
quantit analysi trade idea recommend contain one type barclay research may differ contain
type barclay research whether result differ time horizon methodolog otherwis
http //publicresearch barcap com/s/rd htm order access barclay research conflict manag polici statement pleas refer
procedur pleas
unless otherwis indic price sourc bloomberg reflect close price relev trade market may
last avail price time public
